` 382150 (OnCoCross Co Ltd) vs KOSPI 200 Comparison - Alpha Spread

O
382150
vs
K
KOSPI 200

Over the past 12 months, OnCoCross Co Ltd has underperformed KOSPI 200, delivering a return of +0% compared to KOSPI 200's +119% growth.

Stocks Performance
382150 vs KOSPI 200

Loading...
382150
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
382150 vs KOSPI 200

Performance Gap Between 382150 and KOSPI200
LOCKED
Unlock

Performance By Year
382150 vs KOSPI 200

Loading...
382150
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
OnCoCross Co Ltd vs Peers

KOSPI 200
382150
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

OnCoCross Co Ltd
Glance View

Market Cap
44.3B KRW
Industry
Biotechnology

Oncocross Co., Ltd. engages in conducting joint research on new drugs with several domestic and foreign pharmaceutical companies. The company is headquartered in Seoul, Seoul. The company went IPO on 2024-12-18. The firm mainly develops artificial intelligence (AI) new drug development platform based on its original technology which analyzing changes in gene expression data (Transcriptome) due to drug administration or disease occurrence and using AI to match the optimal disease and treatment. The firm mainly develops treatments for rare diseases, cancer, dementia and other intractable diseases.

Intrinsic Value
Not Available
Back to Top